| |
|
|
|
Alpine Immune Sciences Inc.  
|
|
7.47 0.2 (0.03%) |
04-18 11:47 |
|
Open: |
6.95 |
Pre close: |
7.27 |
Target:
|
9.63 
|
|
High: |
7.47 |
Low: |
6.9 |
Resistance:
|
8.24
9.63
|
|
Volume: |
11,679 |
Market Cap: |
139M |
Support:
|
7.23
6.61
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.42
 |
MACD |
MACD(12,26):
|
0.20 |
|
MA(20): |
7.22 |
Signal(12,26,9): |
0.22 |
|
MA(100): |
5.99 |
Stochastic Oscillator |
%K(14,3):
|
46.13 |
|
MA(250): |
6.58 |
%D(3): |
48.03 |
|
Average Volume(K) |
3-Month: |
1743
|
52-Week |
High:
|
10.57 |
|
10-Days: |
1509 |
Low: |
3.66 |
|
RSI |
RSI(14):
|
58.05 |
Change(%): |
-5.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.630 |
Return on Equity (ttm) |
-60.7 |
Shares Out. (M) |
18.56 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-53.5 |
Shares Float (M) |
18.40 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
-100.0 |
% Held by Institutions |
41.50 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.210 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.84 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.33 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.42 |
P/S |
2772864000.00 |
|
Operating Margin |
-5195.32 |
Levered Free Cash Flow
(M) |
-15.39 |
P/CF |
-4.88 |
|
|
|
|
|
|
